EUVIMEDEUVIMED entdecken
Crossref

Astragaloside IV delays vascular aging by enhancing mitochondrial fatty acid β-oxidation via the MLXIPL-PPARα/PGC-1α axis

Xiangyu Chen, Xiaodie Chen, Nan Xiao, Yutong Yang, Chenghui Li, Yanbin Pan, Huiqun Huang, Xiaodong Duan, Yongan Deng, Chengkai Chen, Shuting Zeng, Simin Yang und 5 weitere

Phytomedicine · 2026-07 · 156 · 158183

DOI: 10.1016/j.phymed.2026.158183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026-07. Verfasst von Xiangyu Chen und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong 510080, China; Key Laboratory of…. Hauptthemen laut MEDLINE: Saponins, Triterpenes, PPAR alpha, Fatty Acids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Beijing Natural Science Foundation, Guangdong Special Support Plan, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Mitochondrial dysfunction and the dysregulation of lipid metabolism are significant contributors to vascular aging, which in turn raises the risk of age-related cardiovascular diseases (CVDs). Buyang Huanwu decoction (BHD), a traditional formula widely used for treating CVDs, has not been thoroughly investigated in terms of its active components and the molecular mechanisms by which it may delay vascular aging. PURPOSE This study aims to investigate the effects and mechanisms of BHD and its primary active component, Astragaloside IV (AS-IV), in mitigating vascular aging, focusing on mitochondrial function and lipid metabolism. METHODS Experiments were conducted using naturally aged mice and a D-galactose-induced model of vascular smooth muscle cells (VSMCs) senescence. Vascular aging was evaluated through aortic histopathology, assessment of senescence markers and senescence-associated secretory phenotype (SASP) factors. Transcriptomics and lipidomics analyses were employed to uncover critical pathways and identify differential lipid profiles. Mitochondrial structure and function were examined using transmission electron microscopy (TEM), Mitochondrial DNA (mtDNA) copy number, and mitochondrial membrane potential (MMP). The molecular mechanisms were further validated through molecular biology and MLX Interacting Protein-Like (MLXIPL) knockdown and overexpression techniques. RESULTS Both BHD and AS-IV improved age-related vascular morphological changes, mitigated elastic fiber disruption, diminished collagen deposition, and downregulated senescence markers along with SASP factors. Transcriptomic analysis identified MLXIPL as a key transcription factor, emphasizing the involvement of the peroxisome proliferator-activated receptor (PPAR) signaling pathway and mitochondrial fatty acid β-oxidation as critical processes. Lipidomic profiling indicated reduced serum acylcarnitine levels in aged mice, suggesting compromised fatty acid β-oxidation. Both BHD and AS-IV were found to suppress MLXIPL, activate PPARα, increase mtDNA copy number, enhance MMP, improve mitochondrial ultrastructure, and upregulate the expression of key genes and proteins associated with mitochondrial biogenesis and fatty acid β-oxidation. Co-immunoprecipitation assays confirmed that AS-IV facilitated PPARα-PGC-1α interaction. Functional validation established that MLXIPL knockdown produced a stronger effect than AS-IV, whereas MLXIPL overexpression negated the beneficial effects of AS-IV on mitochondrial function, lipid accumulation, and cellular senescence. CONCLUSION BHD and its active component AS-IV delay vascular aging by inhibiting MLXIPL, thereby activating the PPARα/PGC-1α signaling pathway to promote mitochondrial fatty acid β-oxidation and reduce lipid accumulation. This elucidates a mechanistic basis for BHD's traditional use and highlights AS-IV as a key active principle with therapeutic potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SaponinsTriterpenesPPAR alphaFatty AcidsMitochondriaPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaAgingAnimalsMiceMuscle, Smooth, VascularMice, Inbred C57BLOxidation-ReductionMaleLipid MetabolismCellular SenescenceDrugs, Chinese HerbalMyocytes, Smooth MuscleAorta

Stichwörter der Autor:innen

Astragaloside IVBuyang Huanwu decoctionFatty acid β-oxidationLipid metabolismMitochondrial biogenesisVascular aging

Substanzen

SaponinsTriterpenesastragaloside APPAR alphaFatty AcidsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPpargc1a protein, mouseDrugs, Chinese HerbalPpara protein, mouse

Autor:innen und Institutionen

  • Department of Cardiology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong 510080, China; Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education, Dep…
  • Department of Cardiology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong 510080, China.
  • Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education, Department of Biology, Faculty of Arts and Sciences, Beijing Normal University, Zhuhai, Guangdong 519087, China; School of Chinese Mate…
  • Department of Integrated Chinese and Western Medicine, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong 510080, China.
  • Department of Traditional Chinese Medicine West China Second University Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
  • Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education, Department of Biology, Faculty of Arts and Sciences, Beijing Normal University, Zhuhai, Guangdong 519087, China. Electronic address: sh…

Förderung

  • Beijing Natural Science Foundation
  • Guangdong Special Support Plan
  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Chen, X., Chen, X., Xiao, N., Yang, Y., Li, C., Pan, Y., Huang, H., Duan, X., Deng, Y., Chen, C., Zeng, S., Yang, S., Huang, Y., Huang, D., Yang, Y., Shu, Z., & Zhang, L. (2026). Astragaloside IV delays vascular aging by enhancing mitochondrial fatty acid β-oxidation via the MLXIPL-PPARα/PGC-1α axis. Phytomedicine, 156, 158183. https://doi.org/10.1016/j.phymed.2026.158183

Vancouver

Chen X, Chen X, Xiao N, Yang Y, Li C, Pan Y, et al. Astragaloside IV delays vascular aging by enhancing mitochondrial fatty acid β-oxidation via the MLXIPL-PPARα/PGC-1α axis. Phytomedicine. 2026;156:158183. doi:10.1016/j.phymed.2026.158183

BibTeX
@article{Chen2026,
  author = {Chen, Xiangyu and Chen, Xiaodie and Xiao, Nan and Yang, Yutong and Li, Chenghui and Pan, Yanbin and Huang, Huiqun and Duan, Xiaodong and Deng, Yongan and Chen, Chengkai and Zeng, Shuting and Yang, Simin and Huang, Yixuan and Huang, Danping and Yang, Yubin and Shu, Zunpeng and Zhang, Li},
  title = {Astragaloside IV delays vascular aging by enhancing mitochondrial fatty acid β-oxidation via the MLXIPL-PPARα/PGC-1α axis},
  journal = {Phytomedicine},
  year = {2026},
  volume = {156},
  pages = {158183},
  doi = {10.1016/j.phymed.2026.158183}
}
Kostenlos starten →